Point72 Asia (Singapore)’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$69K	Buy	59,453 +41,348	+228%	+$48K	0.01%	537
2025 Q1	$28.8K	Buy	18,105 +990	+6%	+$1.57K	0.01%	648
2024 Q4	$51.9K	Buy	+17,115	New	+$51.9K	0.01%	503
2024 Q2	–	Sell	-3,392	Closed	-$53.5K	–	1563
2024 Q1	$53.5K	Buy	+3,392	New	+$53.5K	0.01%	783